← All stocks

Maze Therapeutics, Inc.

MAZE Net selling
CIK 0001842295 #2211 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$22.10M
$4.01M on a plan · $16.96M straight out of an exercise
Sold at will
$1.14M
16 of 91 sales
Net
−$22.10M
−$1.14M against sales at will

By person

10 insiders · 93 transactions

There is no salary here to measure against. Maze Therapeutics, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bernstein Harold
President, R&D & CMO
$9.02M (29) scheduled
−$9.02M
0
0.0000%
$0.00
Coloma Jason V
Chief Executive Officer
$5.25M (23) scheduled
−$5.25M
524,131
0.9435%
$13.74M
−21.7%
Dandekar Atul
CSBO
$5.01M (20) scheduled
−$5.01M
32,316
0.0582%
$847.45K
+170.5%
Bachrodt Amy
SVP, Finance
$1.56M (13) scheduled
−$1.56M
12,965
0.0233%
$339.99K
0.0%
Sohn Catherine A.
Director
$1.15M (2) scheduled
−$1.15M
0
0.0000%
$0.00
Courtney Phillips
GC and Corp. Secretary
$104.77K (4)
−$104.77K
7,007
0.0126%
$183.75K
Third Rock Ventures IV, L.P. entity
10% owner
5,424,758
9.77%
$142.26M
+1,643%
Lim Jonathan E
Director
307,956
0.5544%
$8.08M
HOMCY CHARLES J
Director
38,535
0.0694%
$1.01M
+7.2%
SCHELLER RICHARD H
Director
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
Bernstein Harold
1 Sep 2026
President, R&D & CMO
Sold after exercise
16,141
$26.36
$425.51K
Coloma Jason V
1 Sep 2026
Chief Executive Officer
Sold after exercise indirect
31,908
$26.29
$838.78K
Coloma Jason V
1 Sep 2026
Chief Executive Officer
Sold after exercise indirect
2,593
$26.31
$68.21K
Dandekar Atul
28 Aug 2026
CSBO
Sold after exercise
7,500
$27.58
$206.82K
Bernstein Harold
13 Aug 2026
President, R&D & CMO
Sold after exercise
16,142
$27.61
$445.62K
Dandekar Atul
29 Jul 2026
CSBO
Sold after exercise
400
$27.89
$11.16K
Dandekar Atul
29 Jul 2026
CSBO
Sold after exercise
7,100
$27.31
$193.88K
Bernstein Harold
1 Jul 2026
President, R&D & CMO
Sold after exercise
1,200
$30.34
$36.40K
Bernstein Harold
1 Jul 2026
President, R&D & CMO
Sold after exercise
13,409
$29.87
$400.46K
Dandekar Atul
29 Jun 2026
CSBO
Sold after exercise
7,500
$28.02
$210.15K
Bernstein Harold
1 Jun 2026
President, R&D & CMO
Sold after exercise
1,600
$26.36
$42.17K
Bernstein Harold
1 Jun 2026
President, R&D & CMO
Sold after exercise
13,253
$25.57
$338.94K
Dandekar Atul
29 May 2026
CSBO
Sold after exercise
7,500
$26.34
$197.55K
Bernstein Harold
14 May 2026
President, R&D & CMO
Sold after exercise
15,000
$26.22
$393.35K
Dandekar Atul
29 Apr 2026
CSBO
Sold after exercise
7,500
$25.37
$190.30K
Bachrodt Amy
1 Apr 2026
SVP, Finance
Sold after exercise
300
$30.34
$9.10K
Bachrodt Amy
1 Apr 2026
SVP, Finance
Sold after exercise
2,200
$29.32
$64.51K
Bernstein Harold
1 Apr 2026
President, R&D & CMO
Sold after exercise
300
$31.07
$9.32K
Bernstein Harold
1 Apr 2026
President, R&D & CMO
Sold after exercise
3,348
$30.06
$100.64K
Bernstein Harold
1 Apr 2026
President, R&D & CMO
Sold after exercise
11,352
$29.24
$331.95K
Dandekar Atul
30 Mar 2026
CSBO
Sold after exercise
790
$30.02
$23.71K
Dandekar Atul
30 Mar 2026
CSBO
Sold after exercise
6,710
$29.26
$196.31K
Bernstein Harold
20 Mar 2026
President, R&D & CMO
Sold after exercise
5,044
$50.02
$252.29K
Bernstein Harold
20 Mar 2026
President, R&D & CMO
Sold after exercise
3,795
$49.32
$187.17K
Bernstein Harold
20 Mar 2026
President, R&D & CMO
Sold after exercise
6,161
$48.20
$296.98K
Bernstein Harold
10 Mar 2026
President, R&D & CMO
Sold after exercise
348
$51.02
$17.75K
Bernstein Harold
10 Mar 2026
President, R&D & CMO
Sold after exercise
29,652
$50.45
$1.50M
Bachrodt Amy
2 Mar 2026
SVP, Finance
Sold after exercise
3,700
$45.47
$168.24K
Bachrodt Amy
2 Mar 2026
SVP, Finance
Sold after exercise
1,300
$44.44
$57.77K
Dandekar Atul
27 Feb 2026
CSBO
Sold after exercise
3,761
$45.72
$171.97K
Dandekar Atul
27 Feb 2026
CSBO
Sold after exercise
3,739
$45.13
$168.76K
Bachrodt Amy
2 Feb 2026
SVP, Finance
Sold after exercise
736
$46.63
$34.32K
Bachrodt Amy
2 Feb 2026
SVP, Finance
Sold after exercise
4,064
$46.03
$187.07K
Bachrodt Amy
2 Feb 2026
SVP, Finance
Sold after exercise
200
$44.15
$8.83K
Bernstein Harold
2 Feb 2026
President, R&D & CMO
Sold after exercise
100
$47.23
$4.72K
Bernstein Harold
2 Feb 2026
President, R&D & CMO
Sold after exercise
5,936
$46.37
$275.27K
Bernstein Harold
2 Feb 2026
President, R&D & CMO
Sold after exercise
8,364
$45.89
$383.82K
Bernstein Harold
2 Feb 2026
President, R&D & CMO
Sold after exercise
600
$44.21
$26.52K
Dandekar Atul
29 Jan 2026
CSBO
Sold after exercise
2,800
$45.01
$126.02K
Dandekar Atul
29 Jan 2026
CSBO
Sold after exercise
3,500
$44.04
$154.15K
Dandekar Atul
29 Jan 2026
CSBO
Sold after exercise
1,200
$43.18
$51.82K
Bachrodt Amy
22 Jan 2026
SVP, Finance
Sold after exercise
5,000
$45.52
$227.61K
Sohn Catherine A.
7 Jan 2026
Director
Sold after exercise
26,920
$39.11
$1.05M
Bernstein Harold
7 Jan 2026
President, R&D & CMO
Sold after exercise
25,156
$40.20
$1.01M
Sohn Catherine A.
6 Jan 2026
Director
Sold after exercise
2,493
$38.62
$96.27K
Bernstein Harold
5 Jan 2026
President, R&D & CMO
Sold after exercise
412
$40.00
$16.48K
Bachrodt Amy
2 Jan 2026
SVP, Finance
Sold after exercise
2,595
$39.57
$102.68K
Bachrodt Amy
2 Jan 2026
SVP, Finance
Sold after exercise
2,405
$38.70
$93.07K
Bernstein Harold
2 Jan 2026
President, R&D & CMO
Sold after exercise
4,432
$40.43
$179.19K
Bachrodt Amy
30 Dec 2025
SVP, Finance
Sold after exercise
5,000
$40.08
$200.41K
Dandekar Atul
30 Dec 2025
CSBO
Sold after exercise
100
$40.36
$4.04K
Bachrodt Amy
29 Dec 2025
SVP, Finance
Sold after exercise
600
$41.16
$24.69K
Bachrodt Amy
29 Dec 2025
SVP, Finance
Sold after exercise
9,400
$40.54
$381.07K
Bernstein Harold
29 Dec 2025
President, R&D & CMO
Sold after exercise
17,200
$40.93
$703.93K
Bernstein Harold
29 Dec 2025
President, R&D & CMO
Sold after exercise
27,800
$40.34
$1.12M
Dandekar Atul
29 Dec 2025
CSBO
Sold after exercise
6,035
$41.13
$248.21K
Dandekar Atul
29 Dec 2025
CSBO
Sold after exercise
66,365
$40.51
$2.69M

What was left out

Form 4 filings counted 74
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 57
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 2,171,297
History held since 4 Feb 2025